1,382
Views
4
CrossRef citations to date
0
Altmetric
Editorials: Cell Cycle Features

Characterizing novel anti-oncogenic triterpenoids from ganoderma

ORCID Icon, &
Pages 527-528 | Received 27 Feb 2017, Accepted 30 Mar 2017, Published online: 25 Apr 2018

References

  • Soccol CR, Bissoqui LY, Rodrigues C, Rubel R, Sella SR, Leifa F, de Souza Vandenberghe LP, Soccol VT. Pharmacological properties of biocompounds from spores of the lingzhi or reishi medicinal mushroom ganoderma lucidum (Agaricomycetes): a review. Int J Med Mushrooms 2016; 18:757–67; PMID:27910768; http://dx.doi.org/10.1615/IntJMedMushrooms.v18.i9.10
  • Li X, Wu Q, Bu M, Hu L, Du WW, Jiao C, Pan H, Sdiri M, Wu N, Xie Y, et al. Ergosterol peroxide activates Foxo3-mediated cell death signaling by inhibiting AKT and c-Myc in human hepatocellular carcinoma cells. Oncotarget 2016; 7:33948–59; PMID:27058618
  • Chen S, Li X, Yong T, Wang Z, Su J, Jiao C, Xie Y, Yang BB. Cytotoxic lanostane-type triterpenoids from the fruiting bodies of Ganoderma lucidum and their structure-activity relationships. Oncotarget 2017; 8:10071–84; PMID:28052025
  • Akhtar N, Syed DN, Khan MI, Adhami VM, Mirza B, Mukhtar H. The pentacyclic triterpenoid, plectranthoic acid, a novel activator of AMPK induces apoptotic death in prostate cancer cells. Oncotarget 2016; 7:3819–31; PMID:26683363
  • Pan H, Han Y, Huang J, Yu X, Jiao C, Yang X, Dhaliwal P, Xie Y, Yang BB. Purification and identification of a polysaccharide from medicinal mushroom Amauroderma rude with immunomodulatory activity and inhibitory effect on tumor growth. Oncotarget 2015; 6:17777–91; PMID:26219260; http://dx.doi.org/10.18632/oncotarget.4397
  • Wu N, Xie Y, Yang BB. Anti-cancer drugs for cardioprotection. Cell Cycle 2017; 16:155–6; PMID:27801617; http://dx.doi.org/10.1080/15384101.2016.1242536
  • Xie YZ, Yang F, Tan W, Li X, Jiao C, Huang R, Yang BB. The anti-cancer components of Ganoderma lucidum possesses cardiovascular protective effect by regulating circular RNA expression. Oncoscience 2016; 3:203–7; PMID:27713910

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.